Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials?

Vessel Plus ◽

10.20517/2574-1209.2021.05 ◽

2021 ◽

Vol 2021 ◽

Author(s):

Aldo Pietro Maggioni ◽

Adelaide Iervolino ◽

Felicita Andreotti

Keyword(s):

Clinical Trials ◽

Cardiovascular Prevention ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs

Diabetes Obesity and Metabolism ◽

10.1111/dom.13737 ◽

2019 ◽

Vol 21 (8) ◽

pp. 1978-1984

Author(s):

Tetsuro Tsujimoto ◽

Hiroshi Kajio

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Review for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Author response for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v3/response1 ◽

2019 ◽

Author(s):

Tetsuro Tsujimoto ◽

Hiroshi Kajio

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Author Response ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Review for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Author response for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v2/response1 ◽

2019 ◽

Author(s):

Tetsuro Tsujimoto ◽

Hiroshi Kajio

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Author Response ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Decision letter for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Review for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Review for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Decision letter for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text

Decision letter for "No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes taking non‐steroidal anti‐inflammatory drugs"

10.1111/dom.13737/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Prevention ◽

Beneficial Effects ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Secondary Cardiovascular Prevention

Download Full-text